133 related articles for article (PubMed ID: 2679841)
1. Acute and cumulative effects of carboplatin on renal function.
Sleijfer DT; Smit EF; Meijer S; Mulder NH; Postmus PE
Br J Cancer; 1989 Jul; 60(1):116-20. PubMed ID: 2679841
[TBL] [Abstract][Full Text] [Related]
2. Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.
Fokkema E; de Vries EG; Meijer S; Groen HJ
Cancer Chemother Pharmacol; 2000; 45(1):89-92. PubMed ID: 10647508
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.
Metz-Kurschel U; Kurschel E; Niederle N; Aulbert E
J Cancer Res Clin Oncol; 1990; 116(2):203-6. PubMed ID: 2182639
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6).
Offerman JJ; Meijer S; Mulder NH; Sleijfer DT; Bijster P; Hellendoorn HB; Donker AJ; van der Hem GK
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):447-51. PubMed ID: 3891361
[TBL] [Abstract][Full Text] [Related]
5. Renal dysfunction following high-dose carboplatin treatment.
Mulder PO; Sleijfer DT; de Vries EG; Uges DR; Mulder NH
J Cancer Res Clin Oncol; 1988; 114(2):212-4. PubMed ID: 3280573
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin and renal function.
Smit EF; Sleijfer DT; Meijer S; Mulder NH; Postmus PE
Ann Intern Med; 1989 Jun; 110(12):1034. PubMed ID: 2658713
[No Abstract] [Full Text] [Related]
7. Effect of oxoplatinum and CBDCA on renal functions in rats.
Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
[TBL] [Abstract][Full Text] [Related]
8. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.
Meijer S; Sleijfer DT; Mulder NH; Sluiter WJ; Marrink J; Koops HS; Brouwers TM; Oldhoff J; van der Hem GK; Mandema E
Cancer; 1983 Jun; 51(11):2035-40. PubMed ID: 6340821
[TBL] [Abstract][Full Text] [Related]
9. Effects of gemcitabine on renal function in patients with non-small cell lung cancer.
Gietema JA; Groen HJ; Meijer S; Smit EF
Eur J Cancer; 1998 Jan; 34(1):199-202. PubMed ID: 9624259
[TBL] [Abstract][Full Text] [Related]
10. Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.
Donadio C; Lucchesi A; Ardini M; Cosio S; Fanucchi A; Gadducci A
Ther Drug Monit; 2009 Feb; 31(1):63-9. PubMed ID: 19077927
[TBL] [Abstract][Full Text] [Related]
11. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
[TBL] [Abstract][Full Text] [Related]
12. Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.
Meijer S; Mulder NH; Sleijfer DT; Donker AJ; Sluiter WJ; de Jong PE; Schraffordt Koops H; van der Hem GK
Oncology; 1983; 40(3):170-3. PubMed ID: 6189040
[TBL] [Abstract][Full Text] [Related]
13. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Daw NC; Gregornik D; Rodman J; Marina N; Wu J; Kun LE; Jenkins JJ; McPherson V; Wilimas J; Jones DP
Eur J Cancer; 2009 Jan; 45(1):99-106. PubMed ID: 18996004
[TBL] [Abstract][Full Text] [Related]
14. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
Martinez F; Deray G; Dubois M; Beaufils H; Jacquiaud C; Bourbouze R; Benhmida M; Jaudon MC; Jacobs C
Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
[TBL] [Abstract][Full Text] [Related]
15. Dose-related nephrotoxicity of carboplatin in children.
English MW; Skinner R; Pearson AD; Price L; Wyllie R; Craft AW
Br J Cancer; 1999 Sep; 81(2):336-41. PubMed ID: 10496362
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral cyclosporin on renal function in Crohn's disease.
Lobo AJ; Juby LD; Smith AH; Foster PN; Rothwell J; Pentith J; Poole TW; Axon AT
Dig Dis Sci; 1993 Sep; 38(9):1624-30. PubMed ID: 8359074
[TBL] [Abstract][Full Text] [Related]
17. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
[TBL] [Abstract][Full Text] [Related]
18. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
Skillen AW; Buamah PK; Cantwell BM; Cornell C; Hodson AW; Harris AL
Cancer Chemother Pharmacol; 1988; 22(3):228-34. PubMed ID: 3044631
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
